ASIA

China's healthcare system put to the test as COVID brakes fade

China’s healthcare system put to the test as COVID brakes fade

BAODING, China, Dec 11 (Reuters) – When Li tested positive for COVID-19 on Tuesday in Baoding, northern China, he prepared for a five-day quarantine at a local makeshift hospital in the under the country’s strict pandemic controls. Instead, China the next day abruptly relaxed the policy that made the world’s most populous country an outlier …

China’s healthcare system put to the test as COVID brakes fade Read More »

Herbal Medicine Market Size Expected to Grow by USD 36,636.05 Million: Asia to Contribute 42% of Market Growth - Technavio

Herbal Medicine Market Size Expected to Grow by USD 36,636.05 Million: Asia to Contribute 42% of Market Growth – Technavio

NEW YORK, December 7, 2022 /PRNewswire/ — The Herbal Medicine Market by Product, Distribution Channel and Geography – Forecast and Analysis 2023-2027 report was published by Technavio. The market size is expected to increase by $36,636.05 million at a CAGR of 5.96% between 2022 and 2027. The report provides a comprehensive analysis of regional growth …

Herbal Medicine Market Size Expected to Grow by USD 36,636.05 Million: Asia to Contribute 42% of Market Growth – Technavio Read More »

Listening, Journaling and Meditating: Why Leaders Should Work on Mental Health |  Advertising |  Asia Campaign

Listening, Journaling and Meditating: Why Leaders Should Work on Mental Health | Advertising | Asia Campaign

The era of the invincible and invulnerable CEO is thankfully over. Today, in many leading organizations, the warmth of emotional intelligence is valued as much as the cold, hard facts often found in an analytics culture. As a champion of all their stakeholders, every CEO is responsible for supporting the mental health of their employees …

Listening, Journaling and Meditating: Why Leaders Should Work on Mental Health | Advertising | Asia Campaign Read More »

Rare success in Alzheimer's disease research opens hope for future therapies

Rare success in Alzheimer’s disease research opens hope for future therapies

CHICAGO, Nov 29 (Reuters) – The first big breakthrough in 30 years of Alzheimer’s disease research is giving impetus to clinical trials of “cocktail” treatments targeting the two hallmark proteins associated with the mind-stealing disease, according to interviews with researchers and pharmaceutical executives. Drugmakers Eisai Co Ltd (4523.T) and Biogen (BIIB.O) announced in September that …

Rare success in Alzheimer’s disease research opens hope for future therapies Read More »